Bulk flow and diffusion revisited, and clinical applications

Acta Neurochirurgica, Supplementum

Volumn , Issue 106, 2009, Pages 3-13

  Reulen, Hans J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

antibody; Brain edema; bulk flow; convection enhanced transport; diffusion; fluorescence guided surgery; glioblastomas; malignant gliomas; radioimmunotherapy; resolution; tenascein

Indexed keywords

RHENIUM 188;

BRAIN CORTEX; BRAIN EDEMA; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID FLOW; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIFFUSION COEFFICIENT; FROZEN SECTION; HUMAN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRESSURE GRADIENT; RADIOIMMUNOTHERAPY; THERMODYNAMICS;

EID: 78649369493     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-98811-4_1     Document Type: Conference Paper

References (42)

1. Aaslid R, GrÖger U, Patlak CS, Fenstermacher JD, Huber P, Reulen H-J (1990) Fluid flow rates in human peritumoral edema. Acta Neurochir Suppl 51:152-154
2. Blasberg RG, Gazendam I, Patlak CS, Fenstermacher JP (1980) Quantitative autoradiographic studies of brain edema. In: Cervos- Navarro I, Ferszt R (eds) Brain edema, pathology and therapy. Raven-Press, New York
3. Bruce DA, Ter Weeme C, Kaiser G (1976) The dynamics of small and large molecules in the extracellular space and CSF following cold injury of the cortex. In: Pappius HM, Feindel W (eds) Dynamics of brain edema. Springer, Berlin/Heidelberg/New York, pp 95-97
4. Fenske A, Samii M, Reulen H-J, Hey O (1973) Extracellular space and electrolyte distribution in cortex and white matter of dog brain in cold-induced brain edema. Acta Neurochir 28:81-94
5. GrÖger U, Huber P, Reulen H-J (1994) Formation and resolution of human peritumoral brain edema. Acta Neurochir Suppl 60: 373-374
6. Ito U, Reulen H-J, Huber P (1986) Spatial and quantitative distribution of human peritumoral brain edema in computerized tomography. Acta Neurochir 81:53-60
7. Ito U, Tomita H, Tone O, Shishido T, Hayashi H (1990) Formation and resolution of white matter edema in various types of brain tumors. Acta Neurochir Suppl 51:149-151
8. Ito U, Tomita H, Tone O, Masaoka H, Tominaga B (1994) Peritumoral edema in meningeoma: a contrast enhanced study. Acta Neurochir Suppl 60:361-364
9. Marmarou A, Shapiro K, Poll W, et al. (1976) Studies on kinetics of fluid movements within brain tissue. In: Intracranial pressure III. Springer, Berlin/Heidelberg/New York, pp 1-4
10. Marmarou A, Shulman K, Shapiro K, Poell W (1976) Dynamics of Brain Edema. In: Pappius HM, Feindel W (eds) The time course of brain tissue pressure and local CBF in vasogenic edema. Springer, Berlin/Heidelberg/New York
11. Marmarou A, Nakamura T, Tanak K, Hochwald GM (1984) The time course and distribution of water in the resolution phase of infusion edema. In: Brain edema. Plenum, New York, pp 37-44
12. Nagashima T, Tamaki N, Takada M, Tada Y (1994) Formation and resolution of brain edema associated with brain tumors. A comprehensive theoretical model and clinical analysis. Acta Neurochir Suppl 60:165-167
13. Nakagawa H, Groothuis DR, Owens ES, Fenstermacher JD, Patlak CS, Blasberg RG (1987) Dexamethasone effects on I-125 albumin distribution in experimental RG-2 gliomas and adjacent brain. J Cereb Blood Flow Metab 7:687-701
14. Navalitloha Y, Schwartz ES, Groothuis EN, Allen CV, Levy RM, Groothuis DR (2000) Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors. Neuro-Oncol 8(3): 227-233
15. Okada Y, Hoehn-Berlage M, Bockhorst K, Tolxdorff T, Hossmann K-A (1990) Magnetic resonance imaging and regional biochemical analysis of experimental brain tumors in cats. Acta Neurochir Suppl 51:129-130
16. Reulen H-J, Kreysch HG (1973) Measurement of brain tissue pressure in cold-induced brain edema. Acta Neurochir 29:29-40
17. Reulen H-J, Graham R, Spatz M, Klatzo I (1977) Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosur 46:24-35
18. Reulen H-J, Tsuyumu M, Tack A, Fenske A, Prioleau GR (1978) Clearance of edema fluid into cerebrospinal fluid. A mechanism for resolution of vasogenic brain edema. J Neurosur 48:754-764
19. Reulen H-J, Tsuyumu M (1981) Pathophysiology of formation and resolution of vasogenic brain edema. In: M. de Vlieger, S. deLange, JWF Beks (eds) Brain edema. Wiley, New York, pp 31-47
20. Reulen H-J, Graber S, Huber P, Ito U (1988) Factors affecting the extension of peritumoral brain edema. A CT-study. Acta Neurochir 95:19-24
21. Tsuyumu M, Reulen H-J, Prioleau GR (1981) Dynamics of formation and resolution of vasogenic brain edema. I. Measurement of edema clearance into ventricular CSF. Acta Neurochir 57:1-13
22. Tsuyumu M, Reulen H-J, Inaba Y (1985) II. Dynamics of fluid movement through brain parenchyma and into the CSF in vasogenic edema. In: Inaba Y (ed) Brain edema. Springer, Berlin/Heidelberg, pp 99-107
23. Uhl E, Wrba E, Nehring V, Chang RCC, Baethmann A, Reulen H-J (1999) Technical note: a new model for quantitative analysis of brain edema resolution into the ventricles and the subarachnoid space. Acta Neurochir 141:89-92
24. Stummer W, Goetz C, Hassan A, Heimann A, Kempski O (1993) Kinetics of photofrin II in perifocal brain edema. Neurosurgery 33:1075-1082
25. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz A, Kiefmann R, Reulen H-J (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42:518-526
26. Stummer W, Nowotny A, Stepp H, Goetz C, Bise K, Reulen H-J (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013
27. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H.-J, and the german glioma study group (2006) Fluorescence-guided surgery with 5-ALA for resection of malignant glioma: a randomised controlled multicentre phase III-trial. Lancet Oncol 7:392-401
28. Stummer W, Reulen H-J, Meinel T, Pichlmeier U, Tonn J-C, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T, and the ALA-Glioma Study Group. (2008) Extent of resection and survival in glioblastoma multiforme - identification of and adjustment for bias. Neurosurgery 62:564-56
29. Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, Thorstad WL, McLendon RE, Bigner SH, Zhao XG, Pegram CN, WIkstrand CJ, Herndon JE, Vick NA, Paleologos N, Cokgor I, Provenzale CJ, Zalutzky MR (1998) Iodine-131-labeled antitenascein monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol 16:2202-2212
30. Gildehaus F-J, Rachinger W, Decker M, Stocker S, Goetz C, Poepperl G, Tatsch K, Reulen H-J (2003) Migration properties of a radiolabelled intact antibody and Fab-fragment after locoregional application in C6-glioma of the rat. J Nucl Med 44 (suppl):36
31. Goetz C, Riva P, Tatsch K, Gildehaus F-J (2003) Radioimmunotherapy in selected patients with malignant gliomas, survival time and side-effects. J Neurooncol 62:321-328
32. Goetz C, Rachinger W, Decker M, Gildehaus F-G, Stocker S, Jung G, Tatsch K, Tonn J-C, Reulen H-J (2005) Distribution of labeled anti-tenascein antibodies and fragments after injection into intact or partly resected C6 gliomas in rats. Cancer Immunol Immunother 54:337-344
33. Poepperl G, Goetz C, Gildehaus F-J, Reulen H-J, Hahn K, Tatsch K (2002) Initial experience with locoregional immunotherapy using 131I-labeled monoclonal antibodies against tenascein (BC-4) for treatment of glioma WHO grade III and IV. Nuklearmedizin 41:120-128
34. Riva P, Franceschi G, Arista A, Frattarelli M, Riva N, Cremonini AM, Giuliani G, Casi M (1997) Local application of radiolabeled monoclonal antibodies in the treatment of high grade malignant gliomas: a six-year experience. Cancer 80:2733-2742
35. Riva P, Franceschi G, Frattarelli M, Riva N, Casi M, Santimaria M, Adamo M (2000) Role of nuclear medicine in the treatment of malignant gliomas: The locoregional radioimmunotherapy approach. Eur J Nucl Med 27:601-609
36. Bobo RH, Laske DW, Akbasack A, Morrison PF, Dedrick RL, Oldfield EH (1994) Convection enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076-2080
37. Groothuis DR (2000) The BBB and blood-tumor barrier: a review of strategies for increasing drug delivery. Neuro-Oncol 2:45-59
38. Hall WA, Rustamzadeh E, Asher AL (2003) Convection-enhanced delivery in clinical trials. Neurosurg Focus 14(2):e2
39. Nguyen TT, Pannu YS, Sung C, Dedrick RL, Walbridge S, Brechbiel MW, Garmestani K, Beitzel M, Yordanov AT, Oldfield EH (2003) Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg 98:584-590
40. Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger M, Bankiewicz KS (2004) Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res 64:6858-6862
41. Sampson JH, Raghavan R, Provenzale JM, Croteau D, Reardon DA, Coleman RE, Rodríguez Ponce I, Pastan I, Puri RK, Pedain C (2007) Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. Am J Roentgenol 188(3):703-709
42. Smith JS, Humphrey JAC (2006) Modeling convection enhanced delivery in brain: fluid and mass transport analyses. 9th AIAA/ ASME joint thermophysics and heat transfer conference, 5-8 June, 2006, San Francisco, CA